Protein engineering: Security implications. The increasing ability to manipulate protein toxins for hostile purposes has prompted calls for regulation

EMBO Reports

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Tucker, Jonathan B ^a   Hooper, Craig ^b  

^a MONTEREY INSTITUTE OF INTERNATIONAL STUDIES   (United States)

^b Center for Nonproliferation Studies (CNS)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; BACTERIAL TOXIN; BOTULINUM TOXIN; CELL SURFACE PROTEIN; HYBRID PROTEIN; IMMUNOTOXIN; NATURAL PRODUCT; PROTEIN TOXIN; RICIN; SARIN; SAXITOXIN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOLOGICAL WARFARE; BIOSAFETY; CANCER IMMUNOTHERAPY; CELL KILLING; CUTANEOUS T CELL LYMPHOMA; CYTOTOXICITY; GOVERNMENT REGULATION; HUMAN; INTERNATIONAL COOPERATION; LAW; LETHAL DOSE; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MUSCLE SPASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REGISTRATION; RESEARCH ETHICS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCIENTIFIC MISCONDUCT; TARGET CELL; TERRORISM;

DRUG UTILIZATION; HUMANS; PROTEIN ENGINEERING; RESEARCH; RISK MANAGEMENT; SECURITY MEASURES; TOXINS, BIOLOGICAL;

EID: 33745605537     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400677     Document Type: Article

References (25)

1. Arora N, Williamson LC, Leppla SH, Halpern JL (1994) Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells. J Biol Chem 269: 26165-26171
2. Bartfai T, Lundin SJ, Rybeck B (1993) Benefits and threats of developments in biotechnology and genetic engineering. In SIPRI Yearbook 1993: World Armaments and Disarmament, pp 293-305. Oxford, UK: Oxford University Press
3. Barth H, Roebling R, Fritz M, Aktories K (2002) The binary Clostridium botulinum C2 toxin as a protein delivery system: Identification of the minimal protein region necessary for interaction of toxin components. J Biol Chem 277: 5074-5081
4. Benner SA, Sismour AM (2005) Synthetic biology. Nat Rev Genet 6: 533-543
5. BTWC (1972) Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction. Washington, DC, USA: Biological and Toxin Weapons Convention
6. Ducancel F, Boulain JC, Trémeau O, Ménez A (1989) Direct expression in E. coli of a functionally active protein A-snake toxin fusion protein. Protein Eng 3: 139-143
7. Foss FM (2001) Interleukin-2 fusion toxin: Targeted therapy for cutaneous T cell lymphoma. Ann NY Acad Sci 941: 166-176
8. Gilsdorf JR, Zilinskas RA (2005) New considerations in infectious disease outbreaks: The threat of genetically modified microbes. Clin Infect Dis 40: 1160-1165
9. Gorka S, Sullivan R (2002) Biological toxins: A bioweapon threat in the 21st century. Secur Dialogue 33: 141-156
10. Hamilton MG (1998) Toxins: The emerging threat. ASA Newsl 98 www.asanltr.com/ASANews-98/Toxin.html
11. Kiyokawa T, Williams DP, Snider CE, Strom TB, Murphy JR (1991) Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells. Protein Eng 4: 463-468
12. Kotzin BL, Leung DY, Kappler J, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immunol 54: 99-166
13. Kreitman RJ (2001) Chimeric fusion proteins - Pseudomonas exotoxin-based. Curr Opin Investig Drugs 2: 1282-1293
14. Leitenberg M (2005) Assessing the Biological Weapons and Bioterrorism Threat. Carlisle, PA, USA: Strategic Studies Institute, United States Army War College
15. Madsen JM (2001) Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med 21: 593-605
16. Moon JE (2006) The US biological weapons program. In Wheelis M, Rózsa L, Dando M (eds) Deadly Cultures: Biological Weapons Since 1945, pp 9-46. Cambridge, MA, USA: Harvard University Press
17. OPCW (1993) Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on Their Destruction. The Hague, the Netherlands: Organisation for the Prohibition of Chemical Weapons
18. Petro JB, Carus WS (2005) Biological threat characterization research: A critical component of national biodefense. Biosecur Bioterror 3: 295-308
19. Shaw CA, Starnbach MN (2003) Using modified bacterial toxins to deliver vaccine antigens. ASM News 69: 384-389
20. Shulga-Morskoy S, Rich BE (2005) Bioactive IL7-diphtheria fusion toxin secreted by mammalian cells. Protein Eng Des Sel 18: 25-31
21. Tucker JB (1994) Dilemmas of a dual-use technology: Toxins in medicine and warfare. Politics Life Sci 13: 51-62
22. Ulmer KM (1983) Protein engineering. Science 219: 666-671
23. United States Army Medical Research Institute of Infectious Diseases (2001) Medical Management of Biological Casualties Handbook, 4th edn. Fort Detrick, MD, USA: USAMRIID
24. vanderSpek JC, Murphy JR (2000) Fusion protein toxins based on diphtheria toxin: Selective targeting of growth factor receptors of eukaryotic cells. Meth Enzymol 327: 239-249
25. Vita C, Roumestand C, Toma F, Menez A (1995) Scorpion toxins as natural scaffolds for protein engineering. Proc Natl Acad Sci USA 92: 6404-6408